StockGuru Spotlights
October 4, 2011
TSX-V: DEI
OTCBB: MNEAF, AUGT, DCHAF, SGCNF, NADVF, OILY
Dear Members:
These Spotlights have made tremendous moves. As you can see, StockGuru brings you the very stocks you want on your radar, in your portfolio and to trade.
| StockGuru Spotlight | Spotlight Price | Symbol | High | Up As Much As | Market Cap |
| June 30, 2011 | $0.04 | EPAZ | $0.07 | 75% | $2.31M |
| August 12, 2011 | $0.25 | MGLT | $0.40 | 60% | $9.69M |
| August 23, 2011 | $2.25 | CCLR | $3.25 | 44% | $7.87M |
| July 7, 2011 | $0.25 | EWVE | $0.47 | 88% | $5.77M |
| August 23, 2011 | $0.20 | ACCM | $0.25 | 25% | $8.21M |
| September 20, 2011 | $0.98 | GNBP | $1.12 | 14% | $86.98M |
Genesis Biopharma, Inc. (OTCBB:GNBP), a biotechnology company developing targeted cancer immunotherapies, announced on September 19, 2011, the engagement of four senior industry consultants. “These senior consultants will form a dynamic team to help drive the clinical and commercial progress of Contego(TM), our autologous cell therapy for the treatment of Stage IV metastatic melanoma,” said Anthony Cataldo, president and chief executive officer of Genesis Biopharma. “By utilizing the services of leading consultants, we are able to secure the requisite specialty talent to support our business plan in a cost-effective manner.”
IMPORTANT: Bookmark this link: http://stockguru.com/tag/spotlight Check This Link Every Morning for New Spotlight Stocks All of these are date and time stamped so you know what is current today. You can also just go to STOCKGURU.COM and look for the link in the top navigation for “StockGuru Spotlight.”
You can also put the RSS link into your RSS reader9, such as my favorite “Google Reader.”
There are countless programs that make it easy to get RSS feeds on your wireless phone as well. This is foolproof BUT ONLY IF YOU CHECK YOUR RSS FEED REGULARLY! RSS link on the site. We do not yet send out Spotlight Alerts by email, in an attempt to give your email box a break. Spotlights occur several times weekly, and are released ONLY when we see a valid reason. Occasionally, our Spotlights are compensated picks, but an editorial decision is made as to whether the situation qualifies as a market sensitive pick and we ALWAYS include a disclosure prominently if we include a company for which we have been compensated in either cash or shares.
StockGuru is in its Ninth Year!